Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO · BSE: 524518 · Pharmaceuticals & Biotechnology · 4 announcements

Share price: ₹56.94
Market cap: ₹122.8 Cr
Revenue (annual): ₹23.73 Cr
Net profit (annual): ₹-16.93 Cr
P/E (TTM): -8.7×Sector 50.4×
Promoter holding: 72.74%+0.00% QoQ
FII holding: 0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

6 Aug 2026 13:43 IST BSE

Financial Results

Krebs Biochemicals & Industries Q1 FY27 Results: Net Loss of ₹2.5 Cr, Loss Narrows

Krebs Biochemicals & Industries Ltd reported revenue from operations of ₹7 Cr (+27.3% YoY) and a net loss of ₹2.5 Cr for Q1 FY27.

Key figure: Net loss ₹2.5 Cr

Open full results → Read the filing ↗

21 May 2026 13:23 IST BSE

Financial Results

Krebs Biochemicals & Industries Q4 FY26 Results: Net Loss of ₹2.3 Cr, Loss Narrows

Krebs Biochemicals & Industries Ltd reported revenue from operations of ₹6.8 Cr (+11.5% YoY) and a net loss of ₹2.3 Cr for Q4 FY26.

Key figure: Net loss ₹2.3 Cr

Open full results → Read the filing ↗